Asia-Pacific: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in Asia-Pacific

For the fourth year in a row, the Asia-Pacific medicaments containing corticosteroid hormones market recorded decline in sales value, which decreased by -1.6% to $X in 2021. Overall, consumption showed a mild shrinkage. The level of consumption peaked at $X in 2012; however, from 2013 to 2021, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Corticosteroid Hormones in Asia-Pacific

In value terms, medicaments containing corticosteroid hormones production soared to $X in 2021 estimated in export price. Over the period under review, production showed a noticeable contraction. The growth pace was the most rapid in 2015 with an increase of 41%. Over the period under review, production reached the peak level at $X in 2012; however, from 2013 to 2021, production stood at a somewhat lower figure.

Exports of Medicaments Containing Corticosteroid Hormones

Exports in Asia-Pacific

In 2021, shipments abroad of medicaments containing corticosteroid hormones increased by 32% to X tons, rising for the fifth consecutive year after two years of decline. In general, exports saw a remarkable increase. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

In value terms, medicaments containing corticosteroid hormones exports totaled $X in 2021. The total export value increased at an average annual rate of +2.2% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2014 when exports increased by 30%. Over the period under review, the exports attained the peak figure in 2021 and are expected to retain growth in years to come.

Exports by Country

In 2021, India (X tons) and Pakistan (X tons) were the key exporters of medicaments containing corticosteroid hormones in Asia-Pacific, together making up 63% of total exports. China (X tons) held a 20% share (based on physical terms) of total exports, which put it in second place, followed by Australia (5.7%). Indonesia (X tons) and Japan (X tons) held a minor share of total exports.

From 2012 to 2021, the biggest increases were recorded for Pakistan (with a CAGR of +21.8%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing corticosteroid hormones supplying countries in Asia-Pacific were Japan ($X), India ($X) and China ($X), together comprising 61% of total exports. Australia, Pakistan and Indonesia lagged somewhat behind, together comprising a further 19%.

In terms of the main exporting countries, Australia, with a CAGR of +22.0%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in Asia-Pacific stood at $X per ton in 2021, dropping by -17% against the previous year. Over the period under review, the export price saw a abrupt decrease. The pace of growth was the most pronounced in 2016 when the export price increased by 17% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2017 to 2021, the export prices remained at a lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2021, the country with the highest price was Japan ($X per ton), while Pakistan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Australia (+4.0%), while the other leaders experienced more modest paces of growth.

Imports of Medicaments Containing Corticosteroid Hormones

Imports in Asia-Pacific

Medicaments containing corticosteroid hormones imports expanded markedly to X tons in 2021, rising by 9% against 2020. Total imports indicated a prominent increase from 2012 to 2021: its volume increased at an average annual rate of +6.6% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +80.5% against 2013 indices. The growth pace was the most rapid in 2015 with an increase of 14% against the previous year. The volume of import peaked in 2021 and is expected to retain growth in the immediate term.

In value terms, medicaments containing corticosteroid hormones imports totaled $X in 2021. Total imports indicated a buoyant expansion from 2012 to 2021: its value increased at an average annual rate of +6.1% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +70.7% against 2012 indices. The pace of growth was the most pronounced in 2017 when imports increased by 15%. The level of import peaked in 2021 and is likely to continue growth in years to come.

Imports by Country

In 2021, China (X tons), distantly followed by Japan (X tons), Afghanistan (X tons), Australia (X tons), Vietnam (X tons) and Malaysia (X tons) were the major importers of medicaments containing corticosteroid hormones, together making up 78% of total imports. Pakistan (X tons), South Korea (X tons), Thailand (X tons), Singapore (X tons), Indonesia (X tons) and Taiwan (Chinese) (X tons) took a little share of total imports.

From 2012 to 2021, the biggest increases were recorded for Afghanistan (with a CAGR of +58.8%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, China ($X), Japan ($X) and Australia ($X) constituted the countries with the highest levels of imports in 2021, together comprising 79% of total imports. South Korea, Vietnam, Thailand, Taiwan (Chinese), Singapore, Malaysia, Indonesia, Afghanistan and Pakistan lagged somewhat behind, together comprising a further 16%.

Among the main importing countries, Afghanistan, with a CAGR of +45.5%, recorded the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Asia-Pacific stood at $X per ton in 2021, falling by -5.9% against the previous year. In general, the import price recorded a relatively flat trend pattern. The growth pace was the most rapid in 2017 an increase of 9.8% against the previous year. Over the period under review, import prices reached the maximum at $X per ton in 2014; however, from 2015 to 2021, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2021, the country with the highest price was South Korea ($X per ton), while Afghanistan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Indonesia (+14.2%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :